Literature DB >> 26402751

The Role of Visinin-Like Protein-1 in the Pathophysiology of Alzheimer's Disease.

Magdalena Groblewska1, Paweł Muszyński2, Aleksandra Wojtulewska-Supron3, Agnieszka Kulczyńska-Przybik2, Barbara Mroczko1,2.   

Abstract

Calcium ions are crucial in the process of information transmission and integration in the central nervous system (CNS). These ions participate not only in intracellular mechanisms but also in intercellular processes. The changes in the concentration of Ca2 + ions modulate synaptic transmission, whereas neuronal activity induces calcium ion waves. Disturbed calcium homeostasis is thought to be one of the main features in the pathophysiology of Alzheimer's disease (AD), and AD pathogenesis is closely connected to Ca2 + signaling pathways. The effects of changes in neuronal Ca2 + are mediated by neuronal calcium sensor (NCS) proteins. It has been revealed that NCS proteins, with special attention to visinin-like protein 1 (VILIP-1), might have a connection to the etiology of AD. In the CNS, VILIP-1 influences the intracellular neuronal signaling pathways involved in synaptic plasticity, such as cyclic nucleotide cascades and nicotinergic signaling. This particular protein is implicated in calcium-mediated neuronal injury as well. VILIP-1 also participates in the pathological mechanisms of altered Ca2 + homeostasis, leading to neuronal loss. These findings confirm the utility of VILIP-1 as a useful biomarker of neuronal injury. Moreover, VILIP-1 plays a vital role in linking calcium-mediated neurotoxicity and AD-type pathological changes. The disruption of Ca2 + homeostasis caused by AD-type neurodegeneration may result in the damage of VILIP-1-containing neurons in the brain, leading to increased cerebrospinal fluid levels of VILIP-1. Thus, the aim of this overview is to describe the relationships of the NCS protein VILIP-1 with the pathogenetic factors of AD and neurodegenerative processes, as well as its potential clinical usefulness as a biomarker of AD. Moreover, we describe the current and probable therapeutic strategies for AD, targeting calcium-signaling pathways and VILIP-1.

Entities:  

Keywords:  Alzheimer’s disease; biomarkers; brain injury; neurodegeneration; visinin-like protein-1

Mesh:

Substances:

Year:  2015        PMID: 26402751     DOI: 10.3233/JAD-150060

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  13 in total

Review 1.  Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Current Evidence and Future Perspectives.

Authors:  Donovan A McGrowder; Fabian Miller; Kurt Vaz; Chukwuemeka Nwokocha; Cameil Wilson-Clarke; Melisa Anderson-Cross; Jabari Brown; Lennox Anderson-Jackson; Lowen Williams; Lyndon Latore; Rory Thompson; Ruby Alexander-Lindo
Journal:  Brain Sci       Date:  2021-02-10

Review 2.  Calcium Sensors in Neuronal Function and Dysfunction.

Authors:  Robert D Burgoyne; Nordine Helassa; Hannah V McCue; Lee P Haynes
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-05-01       Impact factor: 10.005

Review 3.  Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders.

Authors:  Anna Morozova; Yana Zorkina; Olga Abramova; Olga Pavlova; Konstantin Pavlov; Kristina Soloveva; Maria Volkova; Polina Alekseeva; Alisa Andryshchenko; Georgiy Kostyuk; Olga Gurina; Vladimir Chekhonin
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

Review 4.  Biofluid Biomarkers of Alzheimer's Disease: Progress, Problems, and Perspectives.

Authors:  Shan Huang; Yan-Jiang Wang; Junhong Guo
Journal:  Neurosci Bull       Date:  2022-03-19       Impact factor: 5.271

Review 5.  Cross-talk between redox signalling and protein aggregation.

Authors:  Loes van Dam; Tobias B Dansen
Journal:  Biochem Soc Trans       Date:  2020-04-29       Impact factor: 5.407

6.  Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease.

Authors:  Hua Zhang; Kok Pin Ng; Joseph Therriault; Min Su Kang; Tharick A Pascoal; Pedro Rosa-Neto; Serge Gauthier
Journal:  Transl Neurodegener       Date:  2018-09-10       Impact factor: 8.014

7.  APOE ε4 Allele Is Associated with Elevated Levels of CSF VILIP-1 in Preclinical Alzheimer's Disease.

Authors:  Lijun Wang; Miao Zhang; Qian Wang; Xianguo Jiang; Kunyi Li; Jun Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2020-04-08       Impact factor: 2.570

8.  A Novel Approach to Bacterial Expression and Purification of Myristoylated Forms of Neuronal Calcium Sensor Proteins.

Authors:  Vasiliy I Vladimirov; Viktoriia E Baksheeva; Irina V Mikhailova; Ramis G Ismailov; Ekaterina A Litus; Natalia K Tikhomirova; Aliya A Nazipova; Sergei E Permyakov; Evgeni Yu Zernii; Dmitry V Zinchenko
Journal:  Biomolecules       Date:  2020-07-10

Review 9.  Fluid Candidate Biomarkers for Alzheimer's Disease: A Precision Medicine Approach.

Authors:  Eleonora Del Prete; Maria Francesca Beatino; Nicole Campese; Linda Giampietri; Gabriele Siciliano; Roberto Ceravolo; Filippo Baldacci
Journal:  J Pers Med       Date:  2020-11-11

Review 10.  Current state of Alzheimer's fluid biomarkers.

Authors:  José Luis Molinuevo; Scott Ayton; Richard Batrla; Martin M Bednar; Tobias Bittner; Jeffrey Cummings; Anne M Fagan; Harald Hampel; Michelle M Mielke; Alvydas Mikulskis; Sid O'Bryant; Philip Scheltens; Jeffrey Sevigny; Leslie M Shaw; Holly D Soares; Gary Tong; John Q Trojanowski; Henrik Zetterberg; Kaj Blennow
Journal:  Acta Neuropathol       Date:  2018-11-28       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.